Drug class
Benzodiazepine anxiolytic; positive allosteric modulator of GABAA receptors
Mechanism of action
Enhances GABA-mediated inhibition through positive allosteric modulation of GABAA receptor complexes at the benzodiazepine binding site, increasing chloride-channel opening and neuronal hyperpolarisation.
General use cases
- Short-term symptomatic treatment of anxiety in countries where medazepam remains authorised; availability is limited and use is subject to benzodiazepine dependence, sedation and withdrawal precautions
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
